Moreover, these studies have indicated that these alterations render the NFKBIA protein incapable of interacting with NF-κB, thus resulting in the loss of NFKBIA activity and the protection of tumor cells from apoptosis. The gene discussed is NFKBIA; the disease is neoplasm.